SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-027483
Filing Date
2018-11-06
Accepted
2018-11-06 16:48:27
Documents
77
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q cara-10q_20180930.htm 10-Q 2245099
2 EX-31.1 cara-ex311_254.htm EX-31.1 16099
3 EX-31.2 cara-ex312_255.htm EX-31.2 16116
4 EX-32.1 cara-ex321_257.htm EX-32.1 6392
  Complete submission text file 0001564590-18-027483.txt   8851748

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT cara-20180930.xml EX-101.INS 2165414
6 XBRL TAXONOMY EXTENSION SCHEMA cara-20180930.xsd EX-101.SCH 55486
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cara-20180930_cal.xml EX-101.CAL 51686
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cara-20180930_def.xml EX-101.DEF 243416
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE cara-20180930_lab.xml EX-101.LAB 417020
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cara-20180930_pre.xml EX-101.PRE 371011
Mailing Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902
Business Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902 203-406-3700
Cara Therapeutics, Inc. (Filer) CIK: 0001346830 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36279 | Film No.: 181163626
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1